Skip to main content
. 2021 Jan 14;13(2):286. doi: 10.3390/cancers13020286

Figure 2.

Figure 2

Association of type of progressive disease (HPD vs. non-HPD) with overall survival (OS) following immunotherapy initiation (ICI).